Lyfebulb – CVS Kidney Care® Innovation Challenge: Accelerating Innovations in Kidney Disease to Improve Health Equity and Outcomes

Austin, TX
May 18-19, 2022

CHALLENGE TIMELINE

November 1, 2021
Applications Open
December 14, 2021
Submission Deadline
February 2022
Finalist Announcement
May 18-19, 2022
Innovation Challenge
May 19, 2022
Winner Announcement

WINNER

Dalton, a former division one athlete at the University of Iowa, suffered career ending injuries from a near-fatal motorcycle accident during his sophomore year. One of the injuries (to his brachial plexus) left him with a paralyzed right arm. After about a year, during which his arm was paralyzed. Dalton underwent an experimental nerve transplant operation and eventually was able to regain full movement of his arm.

With his co-founder Eric Pahl, Dalton started OmniLife in 2016. They connected initially through their common interest in medical technology and their shared connected purpose to organ and tissue transplant.

Dalton Shaull
Co-Founder & CEO

Honorable Mention

Passionate. Unique. Loyal. Resilient. These words are commonly used to describe Sharron S. Rouse. Sharron is an experienced leader with a demonstrated history of working in the education and nonprofit industries. She is skilled in program coordination, leadership, community outreach, and curriculum development. Sharron is a strong educational professional with an Administrator certification focused in Educational Leadership and Administration.

A native of the Washington, DC Metropolitan area, she has dedicated her life to influencing the world as a kidney disease, dialysis, and now transplant survivor. Sharron actively shares her story to bring hope and healing to anyone facing difficult circumstances in life. To expand the scope of her reach, Sharron founded Kindness for Kidneys International, Inc., a nonprofit organization dedicated to educating, encouraging, and empowering kidney warriors and their families. Sharron lives in Maryland with her husband Shawn and daughter Kyla.

Sharron Rouse
Founder & Executive Director

ABOUT THE SUMMIT AND AWARD

The Lyfebulb-CVS Kidney Care® Innovation Challenge will take place in March 2022 and is currently accepting applications through December 14, 2021. Selected applicants will receive an invitation to pitch their ideas and solutions to an expert panel of judges comprised of healthcare industry, medical, and patient leaders over the course of the two-day summit. One entrepreneur will be awarded the 2022 Lyfebulb-CVS Kidney Care Innovation Award, including a $25,000 monetary grant to grow their company. Competing finalists may be considered by CVS Kidney Care for possible partnerships or investment opportunities.rnrnIn addition to presenting their innovative ventures, finalists will have the opportunity to exchange ideas on how to further advance patient innovation in chronic kidney disease (CKD) and end-stage renal disease (ESRD) and engage with Lyfebulb founders, CVS Kidney Care leadership, representatives from the CKD/ESRD patient community, key opinion leaders, and potential investors.rnrnNote: The Summit is currently scheduled to take place in person. However, Lyfebulb will continue to monitor the national, state, and local COVID-19 situation, and the details of this event remain subject to change from in-person to virtual as needed.

SHARE

KEY PILLARS OF INNOVATION

Through Lyfebulb and CVS Kidney Care’s shared commitment to patients and their loved ones, the Lyfebulb-CVS Kidney Care Innovation Challenge is seeking a wide range of solutions to address health disparities among patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD). In order to address the health disparities facing kidney patients and their care partners, we will identify scalable solutions that do one or more of the following:

  • Improve early evaluation for kidney disease
  • Educate health care providers and patients around eGFR kidney function
  • Increase cultural empathy among healthcare workers
  • Remove social barriers that affect kidney health outcomes
  • Increase the diversity of nephrologists

We also encourage the submission of all creative and strategic solutions to provide equitable care and improve patient and care partner outcomes. Primary areas of interest supporting this mission include education and awareness, early identification and disease progression, and overall quality of life.

SHARE

FINALISTS

JUDGES

Keisha L. Gibson, MD, MPH, FASN

Associate Professor of Medicine and Pediatrics, DOM Vice Chair of Diversity and Inclusion, and Chief, Pediatric Nephrology Division at UNC School of Medicine

Jeiran Otmishi

Co-Founder of Rumi Edge

Kevin Longino

CEO at National Kidney Foundation

Jennifer Miller

Executive Director, Commercialization for CVS Kidney Care®

Glenda Roberts

Director, External Relations and Patient Engagement at UW Kidney Research Institute/Center for Dialysis Innovation and Chief Strategy and Operations Officer – Justice, Equity, Diversity and Inclusion Center

CRITERIA FOR APPLYING TO THE CHALLENGE

Applicants from historically underrepresented communities and those personally affected by chronic kidney disease (CKD) or end-stage renal disease (ESRD) are particularly encouraged to submit their ideas.

CATEGORIES OF INNOVATION

  • Devices
  • Consumer products
  • Healthcare IT
  • Healthcare services

ORGANIZATIONS

  • US entities only
  • For-profit companies
  • Non-profit organizations
  • Individuals with registered organizations

STAGES OF DEVELOPMENT

  • Idea stage
  • Early development
  • Mature development

JUDGING CRITERIA

The judging panel will assess the following:

UNMET NEED

  • Strategic basis for addressing health equity challenges facing patients and their care partners
  • How these challenges are specifically being addressed

IMPACT

  • Potential of the innovation to improve the lives of people affected by kidney disease
  • Degree of impact (market impact and patient impact)
  • Measurability of impact

MARKET FEASIBILITY

  • Uniqueness to the market
  • Feasibility of development and implementation
  • Market sustainability

THE CHALLENGE IN NUMBERS

1

NOVEMBER

Applications opened on Monday, November 1, 2021

14

DECEMBER

Applications closed on Tuesday, December 14, 2021, at 11:59 PM EST

2

Days

The Challenge took place May 18-19, 2022

$25

Thousand

One entrepreneur was awarded the 2022 Lyfebulb-CVS Health Innovation Award, including a $25,000 monetary grant to grow their company